Hanmi Pharm Co Ltd
KRX:128940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hanmi Pharm Co Ltd
KRX:128940
|
KR |
|
Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret AS
IST:BRISA.E
|
TR |
|
Zoomd Technologies Ltd
XTSX:ZOMD
|
CA |
|
A
|
Amber Hill Financial Holdings Ltd
HKEX:33
|
HK |
|
Novorossiyskiy Morskoy Torgovyi Port PAO
MOEX:NMTP
|
RU |
|
E
|
EBest Investment & Securities Co Ltd
KOSDAQ:078020
|
KR |
|
I
|
Integrum AB
STO:INTEG B
|
SE |
|
S
|
Suntech SA
WSE:SUN
|
PL |
|
C
|
CSD Water Service Co Ltd
SSE:603903
|
CN |
|
S
|
SF Real Estate Investment Trust
HKEX:2191
|
HK |
|
Jig-Saw Inc
TSE:3914
|
JP |
|
Geomatec Co Ltd
TSE:6907
|
JP |
|
P
|
Petrovietnam Power Corp
VN:POW
|
VN |
|
De La Rue PLC
LSE:DLAR
|
UK |
|
SVG Tech Group Co Ltd
SZSE:300331
|
CN |
|
V
|
Vertu Capital Ltd
LSE:VCBC
|
MY |
|
C
|
Cheng Mei Materials Technology Corp
TWSE:4960
|
TW |
|
Elys Game Technology Corp
F:3UW
|
CA |
Bankruptcy Probability
Hanmi Pharm Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hanmi Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Hanmi Pharm Co Ltd
KRX:128940
|
6.5T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hanmi Pharm Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hanmi Pharm Co Ltd has total debt of 416.2B KRW. This includes both short-term (319.5B KRW) and long-term (96.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.
